illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. Beijing Tongrentang
Company logo

Beijing Tongrentang | Sustainability Performance

https://gf.tongrentang.com
Linkedin

Manufactures and sells traditional Chinese patent medicines.

1997

China

10,001+ employees

Pharmaceuticals

$1B - 10B in revenue

$100M - 500M in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#7263
Overall
#276
in China
#172
in Pharmaceuticals

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

44 out of 312

Overview
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
BioKangtai

China, Hospital & Health Care, Biotechnology


Company logo
Lee's Pharmaceutical

China, Hospital & Health Care, Pharmaceuticals


Company logo
Shandong Buchang Pharmaceuticals

China, Hospital & Health Care, Pharmaceuticals

Market cap

230.8B $, 2026▼51.2% YoY

Revenue

2.4B $, 2025▼7.8% YoY

R&D intensity

1.69% 2025

Market cap

230.8B $, 2026▼51.2% YoY

Revenue

2.4B $, FY2025▼7.8% YoY

EBITDA

292.8M $, FY2025▼9.1% YoY

Operating margin

12% Industry: -24▼24.5% YoY

Revenue & EBITDA

$2.4BFY2025 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

33.9M 2024▼539.9% YoY

Capex

72.8M 2024▲37.6% YoY

R&D intensity

1.7%FY2025

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

9.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

2.5

▼ 2.3%

2023

2.6

▲ 1.8%

2024

2.4

▼ 5.7%

2025

20.5

2028

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Available

Human rights policy

Available

Recycling policy

Not available

Workplace health & safety policy

Available

25%
Independent Directors

4 out of 16 incl. management

Powered by illuminem

Overall score

61

Environment

76

Social

62

Governance

45

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

image report
Available

Sustainability employees


    Available in
    Scale package

    Access
  • Email

  • Email